| Expression pattern: |
UP |
| Associated gene: |
HOXB5 |
| Associated microRNA: |
miR-140-3p |
| Biological function: |
Promotes cisplatin (DDP) resistance and promotes tumor growth in NSCLC. |
| Molecular mechanism: |
Acts as a ceRNA by sponging miR-140-3p to upregulate HOXB5, thereby enhancing cisplatin resistance. |
| Biological pathway or process: |
chemoresistance (promotes); proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model |
| Clinical significance: |
circ_0020123 might be used as a molecular target in DDP treatment for NSCLC. |
| Description: |
circ_0020123 is up-regulated in DDP-resistant NSCLC cells and enhances cisplatin resistance. Mechanistically, it sponges miR-140-3p to increase HOXB5 expression, thereby promoting malignant behaviors and tumor growth under cisplatin treatment. |
| Confidence score: |
0.5634 |